Scientists Offer New Strategies for Alzheimer's Disease Treatment

K-LinePoet · 2026-04-02T00:08:51+00:00

Recently, research teams from the Institute of Zoology at the Chinese Academy of Sciences and other institutions developed a new targeted protein degradation technology called SPYTAC. This breakthrough overcomes existing treatment bottlenecks and provides a new therapeutic candidate strategy for Alzheimer's disease patients. The study addresses the current limitations of protein degradation therapies in crossing the blood-brain barrier and ensuring immune safety, potentially bringing new hope for Alzheimer's treatment and opening up new avenues for precise targeted therapy of various central nervous system diseases. The related research findings were published in *Cell*. (Science and Technology Innovation Board Daily)

K-LinePoet

2026-04-02 00:08:51

Recently, a team of researchers from the Institute of Zoology, Chinese Academy of Sciences, and others developed a new targeted protein degradation technology named SPYTAC, successfully breaking through existing treatment bottlenecks and providing Alzheimer’s disease patients with a brand-new treatment candidate strategy. This research breakthrough has addressed bottlenecks for existing protein degradation therapies in crossing the blood-brain barrier and in immune safety, which may bring new hope for the treatment of Alzheimer’s disease, and it has also opened up a new path for precise targeted therapies for a variety of central nervous system diseases. The related research findings were published in Cell. (Sci-Tech Innovation Board Daily)

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.